TargetMol

BGC0222

Product Code:
 
TAR-T203374
Product Group:
 
Peptides
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
 

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T203374-10mg10 mgEnquire
Quantity:
TAR-T203374-50mg50 mgEnquire
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Austria.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Bioactivity:
BGC0222 is a novel Irinotecan prodrug. As a PEG-cRGD conjugated derivative of Irinotecan, BGC0222 enables the slow and steady release of Irinotecan. It binds to the αVβ3 target with an IC50 of 4.25 uM and has an IC50 of 58.7 uM for αVβ5. BGC0222 can induce angiogenesis and demonstrates significant antitumor activity in various tumors.
Formula:
C1241H2276N64O552
Molwt:
26927.36
Pathway:
Cytoskeletal Signaling
Target:
Integrin

Documents